ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Efficacy and Safety of Angiotensin II Compared to Catecholamine Vasopressors as a First-Line Vasopressor for Perioperative Hypotension in Kidney Transplant Recipients

    G. Urias1, J. Benken1, A. Lichvar2, D. Pierce1, L. Andrews1, K. Dalton3, A. Datta1, H. Nishioka1, E. Benedetti1, S. Benken1

    1University of Illinois at Chicago, Chicago, IL, 2University of California San Diego Health, San Diego, CA, 3St. David's Healthcare, Austin, TX

    *Purpose: Perioperative use of catecholamine vasopressors (CV) in kidney transplantation (KT) have been associated with negative renal outcomes and the development of arrhythmias. A more…
  • 2022 American Transplant Congress

    Comparison of Statin-Associated Adverse Events Across Different Types of Statins in Kidney Transplant Recipients

    S. Bae1, J. Ahn2, M. A. Schnitzler3, K. Lentine4, D. Segev1, M. McAdams-DeMarco1

    1Johns Hopkins University, Baltimore, MD, 2SOM, Johns Hopkins University, Baltimore, MD, 3Surgery, Saint Louis University, St. Louis, MO, 4Saint Louis University, St. Louis, MO

    *Purpose: Statins are the third most prescribed drug class in kidney transplant (KT) recipients. Statin’s safety profile in KT recipients remains unclear, although these individuals…
  • 2022 American Transplant Congress

    Donor Terminal Creatinine – Does It Matter?

    V. G. Menon, Y. Wert, W. Hoffman, D. Ladie, M. Singh, M. Waybill, H. Yang

    UPMC, Harrisburg, PA

    *Purpose: When assessing deceased donor kidneys, the transplantation team studies several donor variables including creatinine. A creatinine that is elevated immediately prior to procurement can…
  • 2022 American Transplant Congress

    A New Chapter In An Evolving Pandemic: Successful Pediatric Liver Transplantation With Covid+ Donors

    M. B. Goss1, F. Munoz2, E. A. Moulton3, S. Pouch4, S. Koohmaraie5, N. Moreno1, J. Goss3, N. Galvan3

    1McGovern Medical School, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 3Baylor College of Medicine, Houston, TX, 4Emory University School of Medicine, Decatur, GA, 5Texas Children's Hospital, Houston, TX

    *Purpose: We report the first two pediatric liver transplants utilizing allografts from COVID+ donors, infected at time of organ procurement, demonstrating a pivotal step toward…
  • 2022 American Transplant Congress

    Identical Kidneys Are Discarded at Higher Rates When Labeled as High KDPI

    C. Crannell, J. Perkins, C. Kling

    University of Washington, Seattle, WA

    *Purpose: The kidney donor risk index (KDRI) and percentile conversion kidney donor profile index (KDPI) were introduced with the Kidney Allocation System (KAS) to provide…
  • 2022 American Transplant Congress

    Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients

    J. Yagan1, T. S. Mahmoud1, A. Hasan2, O. Gheith1, n. El-Serwy1, S. Rida1, M. Mostafa1, M. Shaker1, P. Nair1, T. Alotaibi1

    1Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, 2Immunometabolism, Dasman Diabetes Center, Kuwait, Kuwait

    *Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
  • 2022 American Transplant Congress

    Transplant Combined with Neoadjuvant Therapy Improves Survival for Patients with Liver-Limited, Locally Advanced Intrahepatic Cholangiocarcinoma: A SEER Database Analysis

    G. G. Panayotova1, M. Javle2, S. Pentakota1, F. Paterno1, A. Amin1, L. Brown1, S. Simonishvili1, Y. Qin1, T. Ayorinde1, G. Prakash1, C. Conrad3, J. V. Guarrera1, K. E. Lunsford1

    1Rutgers New Jersey Medical School, Newark, NJ, 2University of Texas, MD Anderson Cancer Center, Houston, TX, 3St. Elizabeth's Medical Center, Boston, MA

    *Purpose: Preliminary single-center data suggest multimodal therapy may improve outcomes for patients with intrahepatic cholangiocarcinoma (iCCA) undergoing liver transplant (LT), particularly in the setting of…
  • 2022 American Transplant Congress

    Post-Kidney Transplant Valacyclovir or Valganciclovir for EBV Prophylaxis: A Randomized Controlled Trial

    P. S. Verghese1, A. Matas2, S. Chinnakotla2, M. Evans3, H. Balfour Jr4

    1Pediatric Nephrology, Northwestern University, Feinberg School of Medicine, Minneapolis, MN, 2Surgery, University of Minnesota Medical School, Minneapolis, MN, 3Biostatistics, University of Minnesota, Minneapolis, MN, 4Lab Medicine & Pathology, University of Minnesota, Minneapolis, MN

    *Purpose: EBV viremia post-kidney transplant (KTx) has no proven prophylaxis.*Methods: In this randomized, open-label trial [NCT01329185], adult and pediatric recipients were randomly assigned (1:1) to…
  • 2022 American Transplant Congress

    Individual and Community-Level Social Determinants of Health in Liver Transplant

    M. Yilma1, R. Cogan2, N. Mehta3, J. Neuhaus2, J. Voelkel4, C. Light5, I. Allen2, R. Hirose2

    1General Surgery, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3UCSF, San Francisco, CA, 4Kaiser Permanente Northern California, San Francisco, CA, 5UCSF Medical Center, San Francisco, CA

    *Purpose: To investigate the individual and census-level social determinants of health on liver transplant listing.*Methods: Retrospective review of patients referred to the University of California…
  • 2022 American Transplant Congress

    Novel Phenotype of Intragraft Endothelial Cells That Modulates CD4+ T Effector-Mediated Rejection

    J. Wedel, K. Liu, T. Seto, S. Kong, D. M. Briscoe

    Boston Children's Hospital, Boston, MA

    *Purpose: Previous studies have suggested that early adoptive transfer of Teff into Rag KO mice bearing cardiac transplants results in acute rejection. However, if transfer…
  • « Previous Page
  • 1
  • …
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences